← Back

CICigna

$280.76-0.05%Real quote · delayedHealth insuranceHealthcare services & payers · 7 peers →

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $274.9B · latest quarter up 6.7% YoY · profitable (FY net income $6.0B) · short activity within its normal range.

FY revenue

$274.9B

2025-12

Latest Q YoY

+6.7%

FY net income

$6.0B

Diluted EPS

$22.33

Short volume

52.7%

20d avg 47.6% · normal

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

2026-04-29passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
2026-03-26passive (13G)VANGUARD GROUP INC

🎯 Market expectations

Expectation reliability High · 77/100

Nasdaq analyst consensus · the pre-news baseline

Next quarter (Sep 2026) consensus$7.46Estimate range $7.44 ~ $7.48 · 7 analystsRevisions (4w):↓1

History: actual vs consensusavg +2.3%

Jun 2026$7.78 vs $7.58+2.64%
Mar 2026$7.79 vs $7.62+2.23%
Dec 2025$8.08 vs $7.87+2.67%
Sep 2025$7.83 vs $7.70+1.69%

The takeaway

It has tracked consensus closely — no systematic over- or under-shooting.

Analyst estimates, not our forecast · not investment advice

What's moving this stock lately

No recent news affecting this stock

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

The 16 engine calls on this chart (hit / miss / pending) are Pro — price and volume only for now▂ volume

📜 Call history (newest first

🔒 Pro only

16 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view

🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.